IRMD (Iradimed) Market Value to Book Value Ratio

Iradimed (IRMD) - corporate logo

The asset value of IRADIMED CORPORATION (IRMD), which currently stands at 10.60 as shown on the chart, is tied to the success of the MRI equipment manufacturer. The company's revenues depend on the upgrading of clinic equipment and device certification. Global sales and steady demand for consumables ensure stability, while outsourcing simple processes to external partners while maintaining internal assembly control eliminates production disruptions.

Market Capitalization to Net Assets: IRADIMED Inc. (IRMD) for 07/04/2022 - 10/27/2026
Finished products of IRADIMED Corp

Specializing in robotic dosing systems for MRI zones, IRADIMED CORPORATION (IRMD) possesses a specific set of intangible assets, the value of which is reflected through the price-to-book (P/B) ratio. By analyzing this P/B ratio chart, an investor assesses the extent of the premium paid for the company's technological superiority or identifies an undervaluation of its actual net assets relative to market quotes.

Direct competitors

Market Capitalization to Book Value Ratio Boston Scientific|EW (edwards.com) - Capitalization to Book Value Ratio|RMD: Market Value to Book Value Ratio|Market Capitalization to Book Value PODD|ZBH - Market Value to Book Value Ratio|Market Capitalization to Net Assets CooperSurgical (COO)|ALGN: Market Capitalization to Book Value Ratio|Market-to-Book Ratio globusmedical.com GMED|TMDX: Market Capitalization to Book Value Ratio|ATEC - Market Cap to Net Assets Ratio|Artivion Inc - Market Capitalization to Book Value Ratio|Enovis Inc. (ENOV) - Market Capitalization to Book Value|IART (Integra LifeSciences) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio ESTA|Market Value to Book Value Ratio Beta Bionics (BBNX)|Market Value to Book Value Ratio Embecta Corp (EMBC)|Market Capitalization to Book Value Ratio TNDM|AXGN - Market Capitalization to Book Value|Market Cap to Net Assets Ratio SI-BONE, Inc.|OFIX - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio BVS|OrthoPediatrics (KIDS) - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Treace Medical (TMCI)|Capitalization to Book Value Ratio Strata Medical (SRTA)|Carlsmed Inc (CARL) - Market Cap to Net Assets Ratio|Market Value to Book Value RXST (rxsight.com)|ClearPoint Neuro - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Stereotaxis Inc STXS|STIM (NeuroStar) - Market Capitalization to Book Value Ratio|SGHT - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Orchestra BioMed|Anika Therapeutics, Inc. (ANIK) - Capitalization to Book Value Ratio|NSPR: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Jin Medical International Ltd|Market Capitalization to Book Value Ratio VANI (Vivani Medical, Inc.)|Market Cap to Net Assets Ratio xtantmedical.com (XTNT)|Market Capitalization to Book Value Ratio NMTC (NeuroOne Medical Technologies)|Modular Medical Inc - Market Capitalization to Book Value Ratio|MYO - Market Value to Book Value Ratio|Envoy Medical Inc. (COCH) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Vivos Therapeutics, Inc VVOS|enVVeno Corp (NVNO) - Market Value to Book Value|Market Capitalization to Book Value Ratio SINT (Sintx Technologies Inc)|Market-to-Book Ratio TNON|LFWD: Market Value to Book Value Ratio|Market Value to Equity Ratio autonomix.com AMIX|Market Cap to Net Assets Ratio IVF (INVO Bioscience, Inc.)|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Market Capitalization to Book Value Ratio AXNX (Axonics, Inc.)|BIOL: Market Capitalization to Book Value|Market Value to Book Value Ratio dynatronics.com (DYNT)|FNA (Paragon 28) - Market Capitalization to Net Assets|Market Value to Book Value Ratio INVO